Investigating brain activity patterns in movement disorders
Official title: Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement
Run by University Hospital, Bordeaux · NCT06241924 · Data updated 2026-11-12
This study is testing how brain activity changes during movement in people with Parkinson's disease and epilepsy to see if it helps us understand their conditions better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Bordeaux) |
| Status | Recruiting |
| Started | February 5, 2024 |
| Main results expected | February 5, 2027 |
| Study ends | February 5, 2027 |
| Registry record updated | July 23, 2025 |
| Trial ID | NCT06241924 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 to 75 with Parkinson's disease who have undergone electrode implantation or individuals with drug-resistant epilepsy undergoing pre-surgical assessment.
✕Probably not a fit
Patients who are unable to provide informed consent or have serious psychiatric or somatic illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research aims to explore the oscillatory activity in the cortico-subcortical network during normal and pathological movements in patients with Parkinson's disease and drug-resistant epilepsy. By utilizing high-resolution electroencephalogram (EEG) and stereo-electro-encephalography (SEEG), the study will collect local field potentials while participants perform a simple motor task. The goal is to understand the relationship between the characteristics of these oscillations and movement patterns, which could provide insights into the underlying mechanisms of these disorders.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of movement disorders and lead to improved treatment strategies for patients with Parkinson's disease and epilepsy.
How similar studies have gone: Other studies have shown promise in understanding brain oscillations in movement disorders, but this specific approach using high-resolution techniques is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria : * Male or Female * Between 18 and 75 years of age * With Parkinson's disease and already operated with implantation of electrodes in the Subthalamic nucleus connected to a PERCEPT (TM) device. * Giving free, informed, written consent signed by the participant and the investigator Or * With drug-resistant epilepsy and benefiting from a phase II pre-surgical assessment with intracerebral electrophysiological exploration by stereo-EEG * With at least one electrode exploring the basal ganglia or the thalamus. * Able to perform the simple motor task * Affiliated or beneficiary of a social security scheme; * Giving free, informed, written consent signed by the participant and the investigator Exclusion criteria: * Be incapable of giving consent personally * Be subject to a legal protection measure or be placed under judicial protection; * Being pregnant or breastfeeding * Present a serious and/or decompensated somatic or psychiatric illness
Where it's running
-
CHU de Bordeaux
Bordeaux, France Recruiting
Study contacts
- Principal investigator: Jérôme AUPY, Docteur — University Hospital, Bordeaux
- Study coordinator: Jérôme AUPY, Docteur
- Email: jerome.aupy@u-bordeaux.fr
- Phone: 05 56 71 43 33
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
-
Using PET/MR imaging to improve diagnosis of brain diseases
This study is testing if using advanced PET/MR imaging with artificial intelligence can help doctors diagnose brain diseases like Alzheimer's and Parkinson's more accurately.
-
Remote neuropsychological assessments for patients with neurological disorders
This study is testing a new online way to check brain function in patients with neurological disorders who have trouble getting to appointments.
-
Neurofeedback with implanted brain electrodes for neurological disorders
This study is testing whether using real-time brain feedback from implanted electrodes can help improve symptoms in people with Parkinson's disease, epilepsy, and essential tremor.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.